A5026192868- Heart Failure Treatment and Management
- Cardiac Valve Diseases and Treatments
- Cardiovascular Function and Risk Factors
- Infective Endocarditis Diagnosis and Management
- Electrolyte and hormonal disorders
- Cardiac Arrhythmias and Treatments
- Hemodynamic Monitoring and Therapy
- Acute Myocardial Infarction Research
- Blood Pressure and Hypertension Studies
- Sphingolipid Metabolism and Signaling
- Cardiac Imaging and Diagnostics
- Ion Transport and Channel Regulation
- Cardiac pacing and defibrillation studies
- Neuroendocrine Tumor Research Advances
- Potassium and Related Disorders
- Coronary Interventions and Diagnostics
Sunnybrook Health Science Centre
2018-2023
University of Toronto
2018-2023
King Saud University
2021-2023
Toronto Public Health
2014-2020
Health Sciences Centre
2018
Mount Sinai Hospital
2016
<h3>Importance</h3> The literature is inconsistent regarding the impact of permanent pacemaker implantation after transcatheter aortic valve replacement. <h3>Objective</h3> To evaluate clinical and economic outcomes in patients who required during index hospitalization <h3>Design, Setting, Participants</h3> This retrospective, population-based cohort study using data from a multicenter registry included underwent replacement procedure April 1, 2010, to March 31, 2015, Ontario, Canada, with...
Abstract Background Conduction disturbances and the need for permanent pacemaker (PPM) implantation remains a common complication transcatheter aortic valve replacement (TAVR), particularly when self‐expanding (SE) valves are used. Aims We compared in‐hospital 30‐day rates of new PPM between patients undergoing TAVR with SE using conventional three‐cusp coplanar technique cusp‐overlap technique. Methods retrospectively without pre‐existing who underwent procedure Evolut R or PRO from July...